Guardian Pharmacy Services Inc

guardianpharmacy.com

What Do They Do?

Provides prescription drugs and pharmacy services to long-term care facilities and their residents, especially those in assisted living and behavioral health communities.

How Do They Make Money?

Revenue comes from prescription and medical-product sales to residents and facilities, with Medicare and Medicaid reimbursing a significant portion. Residents are billed for copayments, and some long-term care facilities are billed directly for pharmaceuticals; claims are submitted electronically for processing at the time of sale.

FY2025 revenue

Who Are Their Customers?

Guardian contracts directly with long-term care facilities; local pharmacy sales teams also build relationships with residents and facility operators. In assisted living and behavioral health communities, residents choose their own pharmacy.

Do Revenues Turn Into Profits?

Yes. It kept 3 cents of every revenue dollar as net income in FY2025 and turned 6 cents into free cash flow.

Operating income, FY2025

5% of revenue

▲ Now profitable vs FY2024 (−$62.9M, −5%)

Net income, FY2025

3% of revenue

▲ Now profitable vs FY2024 (−$110M, −9%)

Free cash flow, FY2025

6% of revenue

▲ +101% vs FY2024 ($43.3M, 4%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▲ +2%; vs $344.3M in Q2 FY2025
Net income: ▲ +142%; vs $9M in Q2 FY2025

Aug 6, 2026 Raised full-year guidance and acquired Wellness Concepts Revenue guidance rose to $1.43 billion to $1.45 billion; after quarter-end, Guardian acquired the long-term care pharmacy.
Jun 22, 2026 Named Will Mudd chief financial officer as David Morris became chief operating officer
Mar 23, 2026 Selling stockholders lost majority voting power Guardian ceased to qualify as a controlled company after the offering.

Who Do They Compete With?

Competes with Omnicare, PharMerica, Remedi SeniorCare, PharmCareUSA, and Polaris Pharmacy Services

Comments